Patriot Investment Management Group’s iShares Evolved U.S. Innovative Healthcare ETF IEIH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-20,441
Closed -$672K 249
2022
Q2
$672K Buy
20,441
+845
+4% +$27.7K 0.07% 136
2022
Q1
$671K Buy
19,596
+3,821
+24% +$126K 0.06% 144
2021
Q4
$559K Buy
15,775
+990
+7% +$34.6K 0.05% 167
2021
Q3
$518K Buy
14,785
+280
+2% +$10.1K 0.05% 170
2021
Q2
$507K Buy
14,505
+1,360
+10% +$45.3K 0.05% 169
2021
Q1
$425K Buy
13,145
+1,045
+9% +$34.8K 0.04% 173
2020
Q4
$391K Buy
12,100
+1,640
+16% +$51.2K 0.06% 137
2020
Q3
$316K Buy
10,460
+2,080
+25% +$63K 0.04% 181
2020
Q2
$251K Buy
+8,380
New +$241K 0.03% 194

Patriot Investment Management Group's IEIH Position: Q3 2022 in Review

Patriot Investment Management Group sold out of iShares Evolved U.S. Innovative Healthcare ETF (IEIH) in Q3 2022, closing a stake of 20,441 shares — an estimated $672K sold.

Patriot Investment Management Group first reported a position in IEIH in Q2 2020 and held it in 9 quarters. The position peaked at $672K in Q2 2022. 0 funds tracked by Wall St. Rank hold IEIH as of Q3 2022.

  • Patriot Investment Management Group reported no remaining iShares Evolved U.S. Innovative Healthcare ETF position as of Q3 2022 after selling out during the quarter.
  • Patriot Investment Management Group sold 20,441 iShares Evolved U.S. Innovative Healthcare ETF shares in Q3 2022, an estimated $672K.
  • Patriot Investment Management Group first reported a position in iShares Evolved U.S. Innovative Healthcare ETF in Q2 2020 and held it in 9 quarters.
  • Patriot Investment Management Group's iShares Evolved U.S. Innovative Healthcare ETF position peaked at $672K in Q2 2022.
  • 0 funds tracked by Wall St. Rank held iShares Evolved U.S. Innovative Healthcare ETF as of Q3 2022.

Based on Patriot Investment Management Group's 13F filing for Q3 2022, filed 3 Nov 2022.